This trial is active, not recruiting.

Condition 3 years cardiac morbidity and mortality
Sponsor Medical University of Graz
Start date February 2008
End date December 2013
Trial size 302 participants
Trial identifier NCT00942786, 19-077 ex 07/08


The investigators hypothesize that the level of perioperative natriuretic peptides is associated with in-hospital and long term major adverse cardiac events.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Consecutive patients undergoing emergency surgery

Primary Outcomes

Major adverse cardiac event
time frame: in-hospital and during 3 years follow-up

Eligibility Criteria

Male or female participants at least 50 years old.

Inclusion criteria: - Emergency surgery: 1. Vascular 2. Intra-abdominal 3. Orthopedic Exclusion Criteria: - Patients unable to provide informed consent - Thoracic surgery - Trauma surgery

Additional Information

Official title Prospective Study to Evaluate the Predictive Value of Brain Natriuretic Peptides for Adverse Long-term Cardiac Outcome
Principal investigator Elisabeth Mahla, M.D.
Description The purpose of the study is to measure levels of brain natriuretic peptides before and after urgent non-cardiac surgery and to evaluate their predictive value for adverse long-term outcome.
Trial information was received from ClinicalTrials.gov and was last updated in November 2013.
Information provided to ClinicalTrials.gov by Medical University of Graz.